Unpublished Clinical Trial Data of MS Drug Alemtuzumab Concerning

News   Jun 16, 2017 | Original Story from Queen Mary's University London

 
Previously Unpublished Clinical Trial Data Explain Effects and Issues of Key MS Drug
 
 
 
 

RELATED ARTICLES

Ingestible Drug-Delivery Materials May Improve Patient Treatment Compliance

News

Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.

READ MORE

Waterlogged Brain Region Helps Scientists Gauge Damage Caused by Parkinson’s Disease

News

Development suggests that fluid changes in a specific brain area could provide a way to track that damage.

READ MORE

Nanoparticle Delivery of Curcumin Induces Tumor Cell Death

News

Attaching curcumin, a component of the common spice turmeric, to nanoparticles can be used to target and destroy treatment-resistant neuroblastoma tumor cells

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE